Canada should block a patent waiver for COVID vaccines
Granting a one-time waiver creates dangerous precedent of nullifying IP rights, jeopardizing future innovation and lives of literally billions of virus victims By David Clement and Yaël Ossowski | Financial Post Global Affairs Canada still has not come to a decision on whether to support an intellectual property rights waiver for COVID-19 vaccines. Canada, along…